- Abstract Number: 146
Immersive Virtual Reality for Management of Amplified Musculoskeletal Pain Syndrome in Adolescents: A Pilot Randomized Controlled Trial
- Abstract Number: 143
Immunological Profiles Following Treatment with Rituximab in Autoimmune Disease
- Abstract Number: 173
Impact of a Nutrition-Focused Quality Improvement Intervention on Hospital Readmission Rates in Henoch-Schönlein Purpura with Gastrointestinal Involvement
- Abstract Number: 161
Impact of the Month of Birth on the Development of Juvenile Idiopathic Arthritis in the United States
- Abstract Number: 176
Implementation of an Abbreviated Neuropsychology Screening Protocol for Patients Diagnosed with Childhood-onset Systemic Lupus Erythematosus
- Abstract Number: 003
Implementing Treat to Target Approach in the Care of Juvenile Idiopathic Arthritis Across a Network of Pediatric Rheumatology Centers
- Abstract Number: 004
Implications of Adopting the Newly Proposed Pediatric Rheumatology International Trials Organization (PRINTO) Classification Criteria for Juvenile Idiopathic Arthritis (JIA): Results from the Research in Arthritis in Canadian Children, Emphasizing Outcomes (ReACCh-Out) Cohort
- Abstract Number: 102
Implications of Positive Tests for ANCA in a Pediatric Population
- Abstract Number: 172
Improved Self-efficacy and Knowledge in Pediatric Rheumatology Among General Pediatric Residents Following the Introduction of a Standardized Teaching Series
- Abstract Number: 174
Improving Hospital Discharge Instructions for Pediatric Rheumatology Patients
- Abstract Number: 037
Improving Pneumococcal Vaccination Rates in Immunosuppressed Rheumatology Patients
- Abstract Number: 008
Incidence and Risk Factors of Hypogammaglobulinemia and Infectious Complications Associated with Rituximab Use in Pediatric Rheumatic Diseases
- Abstract Number: 109
Incidence, Contributing Factors, and Impact of Diagnostic Delay in Juvenile Idiopathic Arthritis: Analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
- Abstract Number: 006
Increasing Rates of Standardized Depression Screening in Youth with Systemic Lupus Erythematosus in a Pediatric Rheumatology Clinic
- Abstract Number: 189
Influenza Immunization: A Quality Assurance Survey in a Pediatric Rheumatology Clinic
- Abstract Number: 180
Influenza Knowledge and Barriers to Vaccination in Immunosuppressed Patients in the Pediatric Rheumatology Clinic
- Abstract Number: 159
Interleukin-18 as a Key Cytokine to Understand Pathology and to Decide Appropriate Therapeutic Strategy in Chronic Arthritic Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 062
Is Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) a Reliable Tool for Detecting Vascular Activity in Treated Childhood-Onset Takayasu’s Arteritis (C-TA)? A Multicenter Study
2020 Pediatric Rheumatology Symposium
April 29-May 2, 2020
The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.